These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 9272338

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
    Uberall MA, Stehr K, Cherry JD, Heininger U, Schmitt-Grohé S, Laussucq S, Eckhardt T.
    Dev Biol Stand; 1997; 89():83-9. PubMed ID: 9272335
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM.
    Vaccine; 2005 May 25; 23(28):3657-67. PubMed ID: 15882526
    [Abstract] [Full Text] [Related]

  • 8. The Gothenburg pertussis vaccine study.
    Trollfors B, Taranger J.
    Dev Biol Stand; 1997 May 25; 89():49-51. PubMed ID: 9333568
    [No Abstract] [Full Text] [Related]

  • 9. Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
    Schmitt-Grohé S, Stehr K, Cherry JD, Heininger U, Uberall MA, Laussucq S, Eckhardt T.
    Dev Biol Stand; 1997 May 25; 89():113-8. PubMed ID: 9272341
    [Abstract] [Full Text] [Related]

  • 10. Efficacy trial of acellular pertussis vaccines; trial I.
    Olin P.
    Dev Biol Stand; 1997 May 25; 89():52-4. PubMed ID: 9333569
    [No Abstract] [Full Text] [Related]

  • 11. A placebo-controlled trial of a pertussis-toxoid vaccine.
    Trollfors B, Taranger J, Lagergård T, Lind L, Sundh V, Zackrisson G, Lowe CU, Blackwelder W, Robbins JB.
    N Engl J Med; 1995 Oct 19; 333(16):1045-50. PubMed ID: 7675047
    [Abstract] [Full Text] [Related]

  • 12. A comparative efficacy trial in Germany in which infants received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) vaccine or DT vaccine.
    Stehr K, Cherry JD.
    Dev Biol Stand; 1997 Oct 19; 89():58-62. PubMed ID: 9333571
    [No Abstract] [Full Text] [Related]

  • 13. Adverse reactions to vaccine: Italian cases in the quinquennium 1986-1990.
    Squarcione S, Vellucci L, Parisi P, D'Amato S, Serio G.
    Ann Ig; 1993 Oct 19; 5(2):81-90. PubMed ID: 7510978
    [No Abstract] [Full Text] [Related]

  • 14. Extensive swelling reaction associated with diphtheria and tetanus toxoids and acellular pertussis vaccine.
    Sekaran NK, Edwards KM.
    Pediatr Infect Dis J; 2006 Apr 19; 25(4):374-5. PubMed ID: 16567996
    [Abstract] [Full Text] [Related]

  • 15. Inappropriate administration of DT/DTP vaccines.
    Nash D.
    J Fam Pract; 1995 Nov 19; 41(5):437. PubMed ID: 7595257
    [No Abstract] [Full Text] [Related]

  • 16. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
    Zepp F, Knuf M, Heininger U, Jahn K, Collard A, Habermehl P, Schuerman L, Sänger R.
    Vaccine; 2004 Jun 02; 22(17-18):2226-33. PubMed ID: 15149781
    [Abstract] [Full Text] [Related]

  • 17. Implications of different study designs for the evaluation of acellular pertussis vaccines.
    Fine PE.
    Dev Biol Stand; 1997 Jun 02; 89():123-33. PubMed ID: 9272342
    [Abstract] [Full Text] [Related]

  • 18. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
    Pichichero ME, Casey JR, Francis AB, Marsocci SM, Murphy M, Hoeger W, Cleary C.
    Clin Pediatr (Phila); 2006 Sep 02; 45(7):613-20. PubMed ID: 16928838
    [Abstract] [Full Text] [Related]

  • 19. Pertussis and the pertussis vaccine.
    McKercher SW.
    S D J Med; 1986 Jan 02; 39(1):5-11. PubMed ID: 3484836
    [No Abstract] [Full Text] [Related]

  • 20. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection.
    Heininger U, Stehr K, Christenson P, Cherry JD.
    Clin Infect Dis; 1999 Mar 02; 28(3):602-4. PubMed ID: 10194085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.